Specialty Pharma Markets & Hospital Markets

AplusA was founded and continues to be led by physicians and Ph.D.’s. Their unique experience has enriched our marketing research team's understanding and knowledge of Specialty Pharma Markets and Hospital Market Research.

Specialty Pharmaceutical Markets are those in which prescribed pharmaceuticals are used to treat specific, complex and often high-cost conditions. AplusA has significant experience conducting international marketing research in numerous specialty pharma markets including, but not limited to:

Wet AMD, RVO, DME, Thrombosis, CML, Cancer, Multiple Myeloma, HIV, Respiratory Syncytial Virus, Allergies, Asthma, Crohn's Disease,  Rheumatoid Arthritis, and Growth Hormone Disorders, Hemophilia, Hepatitis B & C, Infertility, Multiple Sclerosis, Osteoporosis, Parkinson's Disease, Psoriasis, Pulmonary Disorders, PHA, Transplant, Rare Autoimmune Disorders, Orphan Diseases.

AplusA’s unique medical knowledge and market research capabilities, have led to the publishing of AplusA data in several peer-reviewed scientific publications.
Click here to view the list.


Hospital Markets are not homogenous. Conducting a hospital market research study is a lot more complex than in retail or office-based practices due to various factors. Our team’s unparalleled knowledge of international hospital markets and how to conduct insightful hospital market research constantly exceeds our clients’ expectations.

AplusA’s unique knowledge of hospital markets was shared at the Savannah, GA, USA PBIRG (Pharmaceutical Business Intelligence and Research Group) Annual General Meeting when Pierre Pigeon, AplusA's Founder & President, presented Hospitals in fast growing markets China, India and Turkey.